rs574917232

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3

The NM_000260.4(MYO7A):​c.5264C>T​(p.Ala1755Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000509 in 1,551,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000053 ( 0 hom. )

Consequence

MYO7A
NM_000260.4 missense

Scores

3
7
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 5.74
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PM1
In a domain MyTH4 2 (size 149) in uniprot entity MYO7A_HUMAN there are 15 pathogenic changes around while only 5 benign (75%) in NM_000260.4
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO7ANM_000260.4 linkc.5264C>T p.Ala1755Val missense_variant Exon 38 of 49 ENST00000409709.9 NP_000251.3 Q13402-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO7AENST00000409709.9 linkc.5264C>T p.Ala1755Val missense_variant Exon 38 of 49 1 NM_000260.4 ENSP00000386331.3 Q13402-1
MYO7AENST00000458637.6 linkc.5150C>T p.Ala1717Val missense_variant Exon 38 of 49 1 ENSP00000392185.2 Q13402-2
MYO7AENST00000409619.6 linkc.5117C>T p.Ala1706Val missense_variant Exon 39 of 50 1 ENSP00000386635.2 Q13402-8
MYO7AENST00000458169.2 linkc.2690C>T p.Ala897Val missense_variant Exon 18 of 29 1 ENSP00000417017.2 H7C4D8
MYO7AENST00000670577.1 linkn.3104C>T non_coding_transcript_exon_variant Exon 21 of 32 ENSP00000499323.1 A0A590UJ94

Frequencies

GnomAD3 genomes
AF:
0.0000328
AC:
5
AN:
152236
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000115
AC:
18
AN:
156170
Hom.:
0
AF XY:
0.000120
AC XY:
10
AN XY:
83172
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000321
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000219
Gnomad FIN exome
AF:
0.0000650
Gnomad NFE exome
AF:
0.0000492
Gnomad OTH exome
AF:
0.000228
GnomAD4 exome
AF:
0.0000529
AC:
74
AN:
1398824
Hom.:
0
Cov.:
31
AF XY:
0.0000623
AC XY:
43
AN XY:
690194
show subpopulations
Gnomad4 AFR exome
AF:
0.0000316
Gnomad4 AMR exome
AF:
0.000250
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000126
Gnomad4 FIN exome
AF:
0.0000205
Gnomad4 NFE exome
AF:
0.0000435
Gnomad4 OTH exome
AF:
0.0000690
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152354
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000659
Hom.:
0
Bravo
AF:
0.0000416
ExAC
AF:
0.0000370
AC:
4

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Dec 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 05, 2022
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports a deleterious effect on splicing; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

not specified Uncertain:1
Aug 26, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.Ala1755Val variant in MYO7A has not been previously reported in individual s with hearing loss or Usher syndrome, but has been identified in 3/7904 South A sian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadins titute.org). Splice prediction tools suggest the creation of a cryptic 5' splice site; however, this information is not predictive enough to determine pathogeni city. Additional computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Ala1755Val variant is uncertain. -

Usher syndrome type 1B Uncertain:1
Nov 11, 2019
Natera, Inc.
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

MYO7A-related disorder Uncertain:1
May 23, 2023
PreventionGenetics, part of Exact Sciences
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The MYO7A c.5264C>T variant is predicted to result in the amino acid substitution p.Ala1755Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.032% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-76914200-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.32
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.46
T;.;.;T
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;D;D;D
M_CAP
Benign
0.078
D
MetaRNN
Benign
0.14
T;T;T;T
MetaSVM
Benign
-0.45
T
MutationAssessor
Benign
2.0
M;.;.;.
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.9
N;N;N;N
REVEL
Benign
0.16
Sift
Uncertain
0.0020
D;D;D;D
Sift4G
Uncertain
0.0030
D;D;D;D
Polyphen
0.55
P;.;.;.
Vest4
0.29
MVP
0.88
MPC
0.16
ClinPred
0.13
T
GERP RS
5.3
Varity_R
0.62
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.77
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.77
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs574917232; hg19: chr11-76914200; COSMIC: COSV68687250; COSMIC: COSV68687250; API